We are live on ! Find out more
NXTC icon

NextCure
NXTC

43 hedge funds and large institutions have $15.4M invested in NextCure in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

10% more funds holding

Funds holding: 39 → 43 (+4)

0.15% more ownership

Funds ownership: 3.86% → 4.01% (+0.15%)

8% less capital invested

Capital invested by funds: $16.6M → $15.4M (-$1.27M)

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

Holders
43
Holders Change
+4
Holders Change %
+10.26%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$195K
2
AI
Acuitas Investments
Washington
+$104K
3
TCM
Tang Capital Management
California
+$82K
4
MAM
Marquette Asset Management
Minnesota
+$70.4K
5
Renaissance Technologies
Renaissance Technologies
New York
+$52.1K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$341K
2
DCM
DAFNA Capital Management
California
-$214K
3
Citadel Advisors
Citadel Advisors
Florida
-$75.8K
4
Federated Hermes
Federated Hermes
Pennsylvania
-$47.1K
5
ECM
ExodusPoint Capital Management
New York
-$26K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$3.09M – – –
SI
2
Sofinnova Investments
California
$3.05M – – –
Millennium Management
3
Millennium Management
New York
$1.3M -$341K -23,514 -20%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.03M +$232 +16 +0%
BlackRock
5
BlackRock
New York
$1.01M -$9.67K -667 -0.9%
CCC
6
Cable Car Capital
California
$702K +$744K +51,323 New
LFCM
7
Long Focus Capital Management
Puerto Rico
$634K – – –
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$556K – – –
TCM
9
Tang Capital Management
California
$533K +$82K +5,661 +17%
AI
10
Acuitas Investments
Washington
$492K +$104K +7,166 +30%
Citadel Advisors
11
Citadel Advisors
Florida
$428K -$75.8K -5,230 -14%
Federated Hermes
12
Federated Hermes
Pennsylvania
$374K -$47.1K -3,248 -11%
BCM
13
BML Capital Management
Indiana
$349K – – –
Renaissance Technologies
14
Renaissance Technologies
New York
$334K +$52.1K +3,593 +17%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$199K – – –
Morgan Stanley
16
Morgan Stanley
New York
$184K +$195K +13,471 New
Macquarie Group
17
Macquarie Group
Australia
$171K – – –
SCM
18
Sio Capital Management
New York
$148K – – –
BCM
19
Bridgeway Capital Management
Texas
$108K – – –
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$97.9K -$11.9K -823 -10%
Barclays
21
Barclays
United Kingdom
$77K – – –
ACM
22
ADAR1 Capital Management
Texas
$68.9K +$73K +5,035 New
MAM
23
Marquette Asset Management
Minnesota
$66.4K +$70.4K +4,855 New
Two Sigma Advisers
24
Two Sigma Advisers
New York
$65.8K -$609 -42 -0.9%
State Street
25
State Street
Massachusetts
$65.1K – – –
1
2

NXTC Hedge Fund Activity: Q4 2023 in Review

43 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q4 2023, worth a combined $15.4M — down 7.6% from $16.6M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new NXTC positions and 5 closed out — a net gain of 4 holders — while 6 added to existing stakes and 9 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $195K. The largest seller was Millennium Management, cutting an estimated $341K.

  • 43 institutional investors held NextCure (NXTC) as of Q4 2023, up from 39 in Q3 2023.
  • Funds reported $15.4M of NextCure stock for Q4 2023, down 7.6% quarter-over-quarter.
  • 9 funds opened new NextCure positions in Q4 2023 and 5 closed out, a net change of +4 holders.
  • The largest NextCure buyer in Q4 2023 was Morgan Stanley, an estimated $195K added.
  • The largest NextCure seller in Q4 2023 was Millennium Management, an estimated $341K sold.

Based on aggregated 13F filings for Q4 2023.